Latest spike protein News

A promising vaccine approach to induce longer-lasting protective immunity against COVID-19
JCU Researcher has sights on universal protection for flu
Our new vaccine could protect against coronaviruses that haven’t even emerged yet – new study
Statement on the antigen composition of COVID-19 vaccines
New technology uncovers mechanism affecting generation of new COVID variants
Study uncovers consequences of Molnupiravir use to treat COVID-19
How long does immunity last after a COVID infection?
Viruses aren’t always harmful. 6 ways they’re used in health care and pest control
Statement on the antigen composition of COVID-19 vaccines
ATAGI recommendations on use of the Moderna and Pfizer monovalent Omicron XBB.1.5 COVID-19 vaccines
COVID proved the therapeutic potential of RNA technology – making it more available is the next goal
Deuteration continues to be an important characterisation tool in understanding COVID infectivity and severity
Antibody targets omicron and other SARS-CoV-2 variants
Study finds silicon, gold and copper among new weapons against COVID-19
Could Naturally Occurring Amino Acid Lead Us to Cure for Covid?
Update on effectiveness of monoclonal antibodies against COVID variants
ATAGI recommendations on use of Moderna bivalent Covid vaccine
Cold viruses may have helped curb Africa’s Covid deaths
Scientists discover receptor that blocks Covid infection
ATAGI recommendations on use of Pfizer bivalent Covid vaccine 8 February
Nanoscopic tool assesses alternative Covid prevention
Demand booms for experimental mRNA from UQ BASE
Know your COVID risk, and help yourself and others this summer
Experimental vaccines offer long-term protection against severe COVID
New nasal vaccine strategy could improve Covid protection
ATAGI recommendations on use of Pfizer bivalent Covid vaccine
At least two thirds of Australians, including children and adolescents, have had Covid, two national antibody studies find
Vaxzevria receives full Marketing Authorisation in EU for prevention of Covid
‘A silent killer’ – Covid shown to trigger inflammation in brain
Ancient viral DNA in human genome guards against infections
New Omicron subvariant largely evades neutralizing antibodies
Omicron-specific vaccines may give slightly better COVID protection – but getting boosted promptly is best bet
ATAGI statement on use of Moderna bivalent Original/Omicron vaccine
First Omicron-adapted Covid boosters are coming
Novavax vaccine for adolescents aged 12
New generation of corona vaccine shows promising results
New technology binds Covid virus to cotton textiles
COVID vaccine patch fights variants better than needles